Development & Application of Claudin 6-Targeted Therapies in Ovarian, Testicular, & Endometrial Cancers
Time: 2:15 pm
day: Conference Day 1
Details:
- Focusing on Claudin 6 expression in ovarian, testicular, and endometrial cancers and the potential for targeted therapies in these indications
- Uncovering the development and clinical potential of ADCs targeting Claudin 6, including preclinical efficacy and safety data
- Highlighting the safety profile and patient selection criteria for Claudin 6-targeted therapies, including strategies to minimize off-target effects
